Source briefingSeptember 21, 2026Health & Science
Association of a multiple risk factor assessment and intervention program with risk of diabetes: A population-based matched cohort study

Source briefing · A concise briefing based on one linked source. It is intentionally shorter than a full FreedomWitness Evidence Engine analysis.
What the source reports
by Ernst Bergman, Anna Nordström, Lars Nyberg, Peter Nordström Background Type 2 diabetes incidence remains high among older adults and contributes substantially to morbidity and healthcare burden. Most evidence supporting diabetes prevention derives from intensive lifestyle interventions targeting high-risk individuals under controlled trial conditions. The effectiveness of low-intensity, population-based prevention programs embedded in routine care remains uncertain.
We evaluated whether participation in a comprehensive health assessment and counseling program was associated with reduced incidence of diabetes in older adults. Methods and findings…
Evidence note: At this stage FreedomWitness is presenting what this source reports. This briefing does not independently prove every underlying claim and should be read together with the original material.
Source & verification
Primary source: PLOS Medicine · September 21, 2026
FreedomWitness links to the original source so readers can inspect the underlying material and judge the context for themselves.
Continue reading

US Tries but Fails to Dilute UN Human Rights Resolutions
US Attempts to Weaken UN Human Rights Resolutions: An Evidence Review What is established In late 2026, during sessions of the United Nations General…

Medical device makers have gotten worse at disclosing when their products harm people, new study finds. The FDA let them.
What is established A recent peer-reviewed study published in The BMJ and reported by the International Consortium of Investigative Journalists (ICIJ) reveals a decline…

EMA/PE/0000181364
What is established The European Medicines Agency (EMA) has granted a decision regarding a paediatric investigation plan (PIP) for vosoritide as of 8 August…